Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 19:5:47.
doi: 10.3389/fpsyt.2014.00047. eCollection 2014.

The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue

Affiliations
Review

The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue

Ralf Brisch et al. Front Psychiatry. .

Erratum in

  • Front Psychiatry. 2014;5:110. Braun, Anna Katharina [corrected to Braun, Katharina]; Kumaritlake, Jaliya [corrected to Kumaratilake, Jaliya]

Abstract

Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia. The revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and prefrontal brain regions exist in schizophrenia. However, recent research has indicated that glutamate, GABA, acetylcholine, and serotonin alterations are also involved in the pathology of schizophrenia. This review provides an in-depth analysis of dopamine in animal models of schizophrenia and also focuses on dopamine and cognition. Furthermore, this review provides not only an overview of dopamine receptors and the antipsychotic effects of treatments targeting them but also an outline of dopamine and its interaction with other neurochemical models of schizophrenia. The roles of dopamine in the evolution of the human brain and human mental abilities, which are affected in schizophrenia patients, are also discussed.

Keywords: animal models of schizophrenia; cannabis; cognition; dopamine; dopamine receptors; evolution of the human brain; glutamate; schizophrenia.

PubMed Disclaimer

References

    1. Bogerts B, Häntsch J, Herzer M. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry (1983) 18:951–69 - PubMed
    1. Wang YC, Ho UC, Ko MC, Liao CC, Lee LJ. Differential neuronal changes in medial prefrontal cortex, basolateral amygdale and nucleus accumbens after postweaning social isolation. Brain Struct Funct (2012) 217:337–51 10.1007/s00429-011-0355-4 - DOI - PubMed
    1. Perez-Costas E, Melendez-Ferro M, Roberts RC. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 113:287–302 10.1111/j.1471-4159.2010.06604.x - DOI - PMC - PubMed
    1. Lodge DJ, Grace AA. Hippocampal dysregulation of dopamine system function and the pathology of schizophrenia. Trends Pharmacol Sci (2011) 32:507–13 10.1016/j.tips.2011.05.001 - DOI - PMC - PubMed
    1. Yoon JH, Minzenberg MJ, Raouf S, D’Esposito M, Carter CS. Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol Psychiatry (2013) 74(2):122–9 10.1016/j.biopsych.2012.11.018 - DOI - PMC - PubMed